Earnings Feed
Start Free
Home/Filings/3/0001209191-05-003709
3//SEC Filing

MPM ASSET MANAGEMENT INVESTORS 2001 LLC 3

Accession 0001209191-05-003709

CIK 0001114529other
View on SEC.govCompany Profile

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 7:38 PM ET

Size

24.7 KB

Accession

0001209191-05-003709

Insider Transaction Report

Form 3
Period: 2005-01-19
VIACELL INCVIAC
MPM ASSET MANAGEMENT II LLC
10% Owner
Holdings

  • Series E Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (1,666,667 underlying)

  • Series H Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (470,155 underlying)

  • Common Stock Warrant

    (indirect: See Footnote)
    Exercise: $1.50Exp: 2007-11-12→ Common Stock (333,333 underlying)

  • Series J Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (125,000 underlying)

  • Series I Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (194,128 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (666,667 underlying)

  • Series G Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (2,000,000 underlying)
MPM BIOVENTURES GMBH & CO PARALLEL BETEILIGUNGS KG
10% Owner
Holdings

  • Series G Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (2,000,000 underlying)

  • Series H Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (470,155 underlying)

  • Series J Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (125,000 underlying)

  • Common Stock Warrant

    (indirect: See Footnote)
    Exercise: $1.50Exp: 2007-11-12→ Common Stock (333,333 underlying)

  • Series I Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (194,128 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (666,667 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (1,666,667 underlying)
MPM BIOVENTURES II QP LP
10% Owner
Holdings

  • Series J Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (125,000 underlying)

  • Series H Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (470,155 underlying)

  • Common Stock Warrant

    (indirect: See Footnote)
    Exercise: $1.50Exp: 2007-11-12→ Common Stock (333,333 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (666,667 underlying)

  • Series I Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (194,128 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (1,666,667 underlying)

  • Series G Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (2,000,000 underlying)
STEINMETZ MICHAEL
10% Owner
Holdings

  • Common Stock Warrant

    (indirect: See Footnote)
    Exercise: $1.50Exp: 2007-11-12→ Common Stock (333,333 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (1,666,667 underlying)

  • Series G Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (2,000,000 underlying)

  • Series J Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (125,000 underlying)

  • Series H Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (470,155 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (666,667 underlying)

  • Series I Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (194,128 underlying)
MPM ASSET MANAGEMENT II LP
10% Owner
Holdings

  • Series J Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (125,000 underlying)

  • Series H Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (470,155 underlying)

  • Common Stock Warrant

    (indirect: See Footnote)
    Exercise: $1.50Exp: 2007-11-12→ Common Stock (333,333 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (666,667 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (1,666,667 underlying)

  • Series I Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (194,128 underlying)

  • Series G Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (2,000,000 underlying)
MPM BIOVENTURES II LP
10% Owner
Holdings

  • Series G Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (2,000,000 underlying)

  • Series J Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (125,000 underlying)

  • Series I Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (194,128 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (1,666,667 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (666,667 underlying)

  • Series H Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (470,155 underlying)

  • Common Stock Warrant

    (indirect: See Footnote)
    Exercise: $1.50Exp: 2007-11-12→ Common Stock (333,333 underlying)
MPM ASSET MANAGEMENT INVESTORS 2001 LLC
10% Owner
Holdings

  • Series I Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (194,128 underlying)

  • Common Stock Warrant

    (indirect: See Footnote)
    Exercise: $1.50Exp: 2007-11-12→ Common Stock (333,333 underlying)

  • Series H Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (470,155 underlying)

  • Series J Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (125,000 underlying)

  • Series G Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (2,000,000 underlying)

  • Series D Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (666,667 underlying)

  • Series E Preferred Stock

    (indirect: See Footnote)
    Exercise: $0.00→ Common Stock (1,666,667 underlying)
Footnotes (7)
  • [F1]Immediately exercisable.
  • [F2]The securities are held by BB BioVentures L.P.
  • [F3]Each share of Preferred Stock will convert automatically on a 1 for 1 basis into shares of Common Stock upon the closing of Issuer's initial public offering.
  • [F4]The shares are held as follows: 1,720,000 by BB BioVentures, L.P. ("BB BioVentures"), 260,600 by MPM BioVentures Parallel Fund, L.P. ("MPM Parallel") and 19,400 by MPM Asset Management Investors 2000A LLC ("MPM Asset"). BB BioVentures is under common control with MPM Parallel. BAB BioVentures L.P. ("BAB BV"), BAB BioVentures NV and MPM BioVentures I LLC ("BioVentures LLC") are the direct and indirect general partners of BB BioVentures. MPM BioVentures I L.P. ("BioVentures LP") and BioVentures LLC are the direct and indirect general partners of MPM Parallel. The Reporting person is a manager of MPM Investors, BioVentures LLC and MPM Asset. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  • [F5]The shares are held as follows: 404,334 by BB BioVentures, 61,261 by MPM Parallel and 4,560 by MPM Asset.
  • [F6]The shares are held as follows: 111,167 by BB BioVentures, 12,620 by MPM Parallel and 1,213 by MPM Asset.
  • [F7]The shares are held as follows: 130,880 by MPM BioVentures II-QP, L.P. ("BV II QP"), 14,444 by MPM BioVentures II, L.P. ("BV II"), 2,715 by MPM Asset Management Investors 2001 LLC ("AM 2001") and 46,089 by MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG ("BV KG"). MPM Asset Management II, L.P. ("AM II GP") and MPM Asset Management II LLC ("AM II LLC") are the direct and indirect general partners of BV II QP, BV II and BV KG. The Reporting Person is a member of AM 2001 and AM II LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

VIACELL INC

CIK 0001114529

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001264824

Filing Metadata

Form type
3
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 7:38 PM ET
Size
24.7 KB
View on SEC.gov